ArticleFrontiers in immunology2022

NR4A2 may be a potential diagnostic biomarker for myocardial infarction: A comprehensive bioinformatics analysis and experimental validation.

Dongsheng Wei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.